FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel ...

Frost & Sullivan and Jland Biotech have conducted comprehensive research on the global collagen industry and co-published the ...

A shift to ERBB growth factor mediated proliferation away from estrogen signaling is observed in resistant cancer cells in most tumors during treatment, partially facilitated by ERBB receptor ...

“But real estate has moved into a place of more transparency and accountability, which is really what we want, so a proliferation of private and exclusive listings would be a huge step backwards.

Hair loss can happen to anyone. Your genes, certain medical conditions, treatments for disease, and other factors can contribute to partial or, sometimes, total hair loss — not just on your head ...

Stromal fibroblasts are the primary matrix-producing cells and are known to drive both fibrosis and inflammation. To define the temporal responses of fibroblasts to injury, we induced a temporary ...

Histopathologically, PF features chronic inflammation, fibroblast proliferation, and excessive extracellular matrix deposition, predominantly collagen. Unlike inflammatory ILDs, IPF follows an ...

This dual function broadens our understanding of the versatility of non-coding RNAs in controlling complex cellular behaviors, such as fibroblast activation and proliferation in response to injury.